Status:
COMPLETED
Use of FDG PET/CT to Evaluate Crohn Disease
Lead Sponsor:
Eric Turcotte
Conditions:
Crohn Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study will permit to determine the role of FDG PET/CT to diagnose Crohn Disease and recurrence of Crohn disease after having compared results of PET/CT's with results of exams rout...
Detailed Description
Crohn disease is an inflammatory disease of the digestive system that may affect the small and large intestines. Remission and recurrence clinically characterized its development. When recurrence occu...
Eligibility Criteria
Inclusion
- Men or women known having a Crohn's disease de novo diagnosis or a Crohn's disease recurrence based on a seven days questionnaire and a physical exam.
- Men or women with a past history of Crohn's disease but considered clinically in remission based on a seven days questionnaire, a physical exam and a Crohn's disease activity index (CDAI) score \< to 150.
Exclusion
- Men or women less than 18 years of age
- Pregnancy
- Breastfeeding
- Renal failure
- Suspicion of a Crohn's disease infectious complication (abscess,fistula)
- Infectious colitis determined at the initial checkup
- Diabetes
- Severe allergy to iode contrast
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00383344
Start Date
October 1 2006
End Date
May 1 2007
Last Update
December 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUS/CRC
Sherbrooke, Quebec, Canada, J1H 5N4